SOP for Incorporation of Antimicrobial Agents in Nasal Sprays

Auditor

2 months ago

Standard Operating Procedure for Incorporation of Antimicrobial Agents in Nasal Sprays

1) Purpose

This SOP outlines the procedures for incorporating antimicrobial agents in nasal spray formulations to enhance the product’s stability and prevent microbial contamination during use. Antimicrobial agents ensure product safety for long-term use.

2) Scope

This SOP applies to personnel involved in the formulation, preparation, and quality control of nasal sprays containing antimicrobial agents at [Company Name]. It covers the selection, weighing, and testing of antimicrobial agents in nasal sprays.

3) Responsibilities

Operators: Responsible for accurately weighing and incorporating antimicrobial agents into nasal spray formulations.
Quality Assurance (QA): Ensures that the antimicrobial agents are evenly distributed in the formulation and that the product meets microbial stability standards.
Maintenance Team: Ensures all equipment used in the formulation process is clean, calibrated, and maintained.

4) Procedure

4.1 Preparation of Ingredients

4.1.1 Selection of Antimicrobial Agents

Select appropriate antimicrobial agents based on the formulation’s intended use and regulatory guidelines. Common agents include benzalkonium chloride, phenoxyethanol, and parabens.
Document the selection of antimicrobial agents in the batch manufacturing record (BMR) and ensure

their concentrations fall within regulatory limits.

4.1.2 Weighing of Ingredients

Weigh the antimicrobial agents using a calibrated balance. Record the weights in the BMR, ensuring accuracy within ±2% of the target weight.
Transfer the weighed antimicrobial agents to a clean, sterile mixing vessel.

4.2 Incorporation of Antimicrobial Agents

4.2.1 Addition to Aqueous Phase

For solution-based nasal sprays, dissolve the antimicrobial agents in the aqueous phase. Stir continuously using a mechanical stirrer until the agents are fully dissolved and uniformly distributed.
Document the stirring speed and time in the BMR. Ensure no residual solids or undissolved agents remain in the solution.

4.2.2 Testing for Uniformity

Take samples from different points in the mixing vessel to test the uniform distribution of antimicrobial agents. Use a validated method (e.g., HPLC or UV spectrophotometry) to measure the concentration of antimicrobial agents across the samples.
Document the results in the homogeneity testing log, ensuring the deviation does not exceed 2%.

4.3 Filling and Packaging

4.3.1 Filling Process

Transfer the prepared nasal spray formulation into the filling machine. Set the machine to dispense the required dose per unit (e.g., 50 µL per spray).
Test the fill accuracy by weighing 10 randomly selected filled units. The variation should not exceed ±5% of the target dose. Document the results in the BMR.

4.3.2 Packaging and Labeling

Seal the filled nasal spray containers with sterile caps or nozzles. Ensure that the containers are free from leaks and defects before packaging.
Label the containers with batch numbers, expiration dates, and instructions for use. Package the containers in protective packaging to prevent contamination during storage and distribution.

4.4 Quality Control

4.4.1 Microbial Stability Testing

Test the microbial stability of the nasal spray by performing preservative efficacy testing (PET) in accordance with pharmacopeial guidelines (e.g., USP <51>). Record the results in the preservative efficacy testing log.

4.4.2 Stability Testing

Conduct long-term and accelerated stability testing to assess the physical and chemical stability of the product. Store samples under controlled environmental conditions (e.g., 25°C, 60% RH) and test at regular intervals (e.g., 1 month, 3 months, 6 months).
Record all test results in the stability testing log and adjust the expiration date as needed based on the stability findings.

4.5 Documentation

Document all steps of the formulation process in the BMR, including the weighing of ingredients, mixing process, and testing results.
Ensure QA personnel review and sign off on all documentation before product release.

4.6 Equipment Cleaning and Calibration

Clean and sterilize all equipment used in the preparation of the nasal spray formulation, including mixers and filling machines, as per the cleaning validation protocol.
Calibrate the equipment as per the calibration schedule and record the results in the cleaning and calibration logs.

5) Abbreviations, if any

API: Active Pharmaceutical Ingredient
QA: Quality Assurance
HPLC: High-Performance Liquid Chromatography
BMR: Batch Manufacturing Record

6) Documents, if any

Batch Manufacturing Record (BMR)
Preservative Efficacy Testing Log
Homogeneity Testing Log
Stability Testing Log
Cleaning Log
Calibration Log

7) References, if any

USP <51> – Antimicrobial Effectiveness Testing
FDA Guidance for Nasal Drug Products

8) SOP Version

Version 1.0

Annexure

1. Preservative Efficacy Testing Log Template

Date	Formulation	Preservative	Microbial Count Reduction (%)	Operator Initials	QA Approval
DD/MM/YYYY	Formulation Name	Preservative Name	Initial You said: Continue ChatGPT said: ChatGPT html Copy code Microbial Count (%)	Operator Name	QA Name

2. Homogeneity Testing Log Template

Date	Formulation	Test Point (Top/Middle/Bottom)	Antimicrobial Agent Concentration (%)	Operator Initials	QA Approval
DD/MM/YYYY	Formulation Name	Test Point	Concentration	Operator Name	QA Name

3. Stability Testing Log Template

Date	Formulation	Storage Conditions	Time Interval	Stability Results	Operator Initials	QA Approval
DD/MM/YYYY	Formulation Name	Temperature and Humidity	1 month, 3 months, etc.	Pass/Fail	Operator Name	QA Name

4. Cleaning Log Template

Date	Equipment ID	Cleaning Procedure	Operator Initials	QA Approval
DD/MM/YYYY	Equipment Name/ID	Cleaning Method	Operator Name	QA Name

5. Calibration Log Template

Date	Equipment ID	Calibration Procedure	Calibration Results	Operator Initials	QA Approval
DD/MM/YYYY	Equipment Name/ID	Calibration Method	Pass/Fail	Operator Name	QA Name